文献速递妇科

患者炎症状态与CD4+/CD8+上皮内肿瘤淋巴细胞浸润预测高级别浆液性卵巢癌结局

Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2018-08-02

该研究在128例高级别浆液性卵巢癌(HGSOC)患者中评估中性粒细胞与淋巴细胞比值(NLR)、血清乳酸脱氢酶(LDH)、肿瘤浸润淋巴细胞(TILs)、PDL1及减瘤手术质量对无进展生存期(PFS)和总生存期(OS)的预测价值。单因素分析显示NLR、LDH、减瘤手术及上皮内TILs对PFS和OS均有显著影响;多因素分析证实上皮内CD4+ T细胞、全身炎症指标、PDL1和减瘤手术是更好OS和PFS的决定因素。结论认为全身炎症和TILs是HGSOC中OS的早期决定因素,上皮内CD4+细胞与PFS和OS增加相关,上皮内CD8+细胞与PFS增加相关,联合评分可能具有预后价值。

要点

  • 在128例HGSOC患者中,NLR、血清LDH、减瘤手术和上皮内TILs对PFS和OS有显著影响。
  • 多因素分析证实上皮内CD4+ T细胞、全身炎症指标、PDL1和减瘤手术是更好OS和PFS的决定因素。
  • 上皮内CD8+细胞与PFS增加相关,联合炎症与TILs的评分可能具有预后价值。

核心结论

  • 全身炎症和TILs是HGSOC中OS的早期决定因素。
  • 减瘤手术质量和PDL1等其他变量也改善患者生存。
  • 上皮内CD4+细胞与PFS和OS增加相关,上皮内CD8+细胞与PFS增加相关。
  • 联合全身炎症与TILs的评分可能对HGSOC患者具有预后价值。

研究设计与样本

  • 研究纳入128例高级别浆液性卵巢癌(HGSOC)患者,评估NLR、血清LDH、TILs、PDL1及减瘤手术质量对PFS和OS的预测价值。

主要发现

  • 初始单因素分析显示全身炎症指标(NLR和血清LDH)、减瘤手术及上皮内TILs对PFS和OS均有显著影响。
  • 调整多个变量后,多因素分析证实上皮内CD4+ T细胞、全身炎症指标、PDL1和减瘤手术是更好OS和PFS的决定因素。
  • 上皮内CD4+细胞与PFS和OS增加相关,上皮内CD8+细胞与PFS增加相关。

临床怎么用

  • 作者认为联合全身炎症与TILs的评分可能对HGSOC患者具有预后价值。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High-grade serous ovarian cancer (HGSOC) is the most prevalent and aggressive histologic type of ovarian cancer. To date, there are no reliable biomarkers to effectively predict patient prognosis. Studies have demonstrated inflammation and tumor infiltrating lymphocytes (TILs) correlate with a bad and good prognosis, respectively. Here, we sought to evaluate systemic inflammation and TILs as early prognostic markers of survival. METHODS: Neutrophil-to-lymphocyte ratio (NLR) and serum Lactate Dehydrogenase (LDH) were used as indicators of systemic inflammation. NLR, serum LDH, tumor infiltrating lymphocytes (TILs), PDL1 and quality of debulking surgery were evaluated as determinants of progression-free survival (PFS) and overall survival (OS) in a cohort of 128 HGSOC patients. RESULTS: Initial univariate analysis showed that systemic inflammation measures (NLR and serum LDH), debulking surgery, and intra-epithelial TILs have a significant impact on both PFS and OS. After adjustment for several variables, multivariate analyses confirmed intraepithelial CD4+ T-cells, systemic inflammation measures, PDL1 and debulking surgery as determinants of better OS and PFS. CONCLUSIONS: Systemic inflammation and TILs are early determinants of OS in HGSOC. Other variables such as the quality of debulking surgery and PDL1 also improve survival of patients. Regarding TIL sub-populations, intraepithelial CD4+ cells are associated to an increase in both PFS and OS. We also confirmed previous reports that demonstrate intraepithelial CD8+ cells correlate with an increase on PFS in ovarian cancer. A combined score using systemic inflammation and TILs may be of prognostic value for HGSOC patients.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Pinto MP, Balmaceda C, Bravo ML, et al. Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer. Gynecol Oncol. 2018. PMID: 30078505. doi:10.1016/j.ygyno.2018.07.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。